Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
Clinical trial NCT01572753 · COMPLETED
Trial details
- NCT number
- NCT01572753
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-12
- Primary completion
- 2012-09-08
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.